Home LiteratureArticle Details
PMID: 12913198 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.

Neurology ·Vol. 61 ·No. 3 ·2003-08-12 ·Pages 358-64

Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Jagust WJ, Chui HC, Kramer JH, Reed BR, Miller BL, Yaffe K, Weiner MW

Abstract

1) To determine the regional pattern of reduced N-acetylaspartate (NAA) in subcortical ischemic vascular dementia (SIVD); 2) to explore the relationship between NAA reduction and subcortical vascular disease; and 3) to test if MR spectroscopic imaging (MRSI) in combination with structural MRI improves differentiation between SIVD and Alzheimer disease (AD). Thirteen patients with SIVD (71 +/- 8 years old) and 43 patients with AD of comparable age and dementia severity were studied using MRSI and MRI. Patients were compared to 52 cognitively normal subjects with and without lacunes. Compared to controls, patients with SIVD had lower NAA by 18% (p < 0.001) in frontal cortex and by 27% (p < 0.003) in parietal cortex, but no significant NAA reduction in white matter and medial temporal lobe. Compared to patients with AD, patients with SIVD had lower NAA by 13% (p < 0.02) in frontal cortex and by 20% (p < 0.002) in left parietal cortex. Cortical NAA decreased in SIVD with increasing white matter lesions (r = 0.54, p < 0.02) and number of lacunes (r = 0.59, p < 0.02). Thalamic lacunes were associated with greater NAA reduction in frontal cortex than were lacunes outside the thalamus (p < 0.02) across groups, after adjusting for cognitive impairments. Adding parietal NAA to MRI-derived hippocampal atrophy improved separation between SIVD and AD (p = 0.02) from 79 to 89%. These results emphasize the importance of cortical dysfunction as a factor in SIVD and indicate a characteristic pattern of metabolite change that might serve as a basis for improved diagnosis.

MeSH Terms
Aged Alzheimer Disease/diagnosis,metabolism Aspartic Acid/analogs & derivatives,analysis,metabolism Brain/metabolism,pathology Dementia, Vascular/diagnosis,metabolism Diagnosis, Differential Female Humans Magnetic Resonance Imaging Magnetic Resonance Spectroscopy Male Neuropsychological Tests Predictive Value of Tests Reference Values
Chemicals
Aspartic Acid N-acetylaspartate
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Schuff N
Magnetic Resonance Unit, DVA Medical Center San Francisco, CA 94121, USA. [email protected]
Capizzano A A
Du A T
Amend D L
O'Neill J
Norman D
Jagust W J
Chui H C
Kramer J H
Reed B R
Miller B L
Yaffe K
Weiner M W
References (32)
32 references, click to expand
  1. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
    AJNR Am J Neuroradiol. 2000 Apr;21(4):621-30 PMID: 10782769
  2. Can PET data differentiate Alzheimer's disease from vascular dementia?
    Ann N Y Acad Sci. 2000 Apr;903:252-61 PMID: 10818514
  3. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
    Neurology. 2000 Jul 25;55(2):210-7 PMID: 10908893
  4. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas.
    Cereb Cortex. 2001 Jan;11(1):1-16 PMID: 11113031
  5. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.
    Neurology. 2000 Dec 12;55(11):1626-35 PMID: 11113215
  6. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.
    Magn Reson Med. 2001 May;45(5):899-907 PMID: 11323817
  7. Reliability of tissue volumes and their spatial distribution for segmented magnetic resonance images.
    Psychiatry Res. 2001 May 30;106(3):193-205 PMID: 11382541
  8. Dementia due to subcortical ischemic vascular disease.
    Clin Cornerstone. 2001;3(4):40-51 PMID: 11432121
  9. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.
    Neurology. 2001 Dec 26;57(12):2229-35 PMID: 11756602
  10. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.
    Neurology. 2002 Mar 26;58(6):928-35 PMID: 11914410
  11. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
    Neurology. 2002 Jun 11;58(11):1635-41 PMID: 12058091
  12. Cerebral changes associated with senility. I. The role of transneuronal degeneration in the neocortex.
    Bol Estud Med Biol. 1973 Jan;28(1):1-8 PMID: 4804954
  13. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
    J Psychiatr Res. 1975 Nov;12(3):189-98 PMID: 1202204
  14. Lacunar strokes and infarcts: a review.
    Neurology. 1982 Aug;32(8):871-6 PMID: 7048128
  15. Cortical topography of thalamic intralaminar nuclei.
    Brain Res. 1985 Mar 4;328(2):333-40 PMID: 3986531
  16. Afferent connections of the thalamic intralaminar nuclei in the cat.
    Brain Res. 1985 Jun 3;335(2):281-96 PMID: 4005556
  17. Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man.
    Brain. 1986 Dec;109 ( Pt 6):1243-59 PMID: 3491655
  18. Spatial localization in NMR spectroscopy in vivo.
    Ann N Y Acad Sci. 1987;508:333-48 PMID: 3326459
  19. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.
    Neurology. 1988 Mar;38(3):359-64 PMID: 3347338
  20. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.
    Neurosci Biobehav Rev. 1989 Spring;13(1):23-31 PMID: 2671831
  21. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.
    Neurology. 1992 Mar;42(3 Pt 1):473-80 PMID: 1549205
  22. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging.
    Neurology. 1992 Sep;42(9):1743-50 PMID: 1513464
  23. Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study.
    Magn Reson Med. 1995 May;33(5):595-600 PMID: 7596262
  24. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.
    Radiology. 1996 Feb;198(2):537-45 PMID: 8596863
  25. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.
    Neurology. 1996 Mar;46(3):678-81 PMID: 8618666
  26. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    Arch Neurol. 1996 Feb;53(2):167-74 PMID: 8639067
  27. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia.
    Arch Neurol. 1996 Jul;53(7):678-80 PMID: 8929176
  28. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study.
    Neurology. 1997 Dec;49(6):1513-21 PMID: 9409338
  29. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images.
    J Comput Assist Tomogr. 1998 Sep-Oct;22(5):838-43 PMID: 9754126
  30. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction.
    Dev Neurosci. 1998;20(4-5):271-6 PMID: 9778562
  31. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging.
    Magn Reson Med. 1998 Dec;40(6):822-31 PMID: 9840826
  32. Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function.
    Arch Neurol. 1999 Jul;56(7):809-14 PMID: 10404982
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
1526-632X
Published
2003-08-12
Pages
358-64
Language
English
Region
United States
NLM ID
0401060
PMCID
PMC1820863
Subset
IM
Grants
NIA NIH HHS · P01 AG012435 · United States
NIA NIH HHS · R01 AG010897 · United States
NIA NIH HHS · AG10897 · United States
NIA NIH HHS · AG12435 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]